Twenty-Four-Week UACR Response Trajectories and Clinical Correlates of Residual Albuminuria in Diabetic Kidney Disease During Finerenone Therapy: A Real-World Longitudinal Study.

Zhang Y, Zhu Q, Wang C, Cai X, Lin S, Ding B, Zhu X, Lin Y

Open source

DOI
10.2147/dmso.s638418
Published
2026
Container
Diabetes, metabolic syndrome and obesity : targets and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/dmso.s638418,
  title = {Twenty-Four-Week UACR Response Trajectories and Clinical Correlates of Residual Albuminuria in Diabetic Kidney Disease During Finerenone Therapy: A Real-World Longitudinal Study.},
  author = {Zhang Y and Zhu Q and Wang C and Cai X and Lin S and Ding B and Zhu X and Lin Y},
  year = {2026},
  journal = {Diabetes, metabolic syndrome and obesity : targets and therapy},
  doi = {10.2147/dmso.s638418},
  url = {https://doi.org/10.2147/dmso.s638418}
}

RIS

TY  - JOUR
TI  - Twenty-Four-Week UACR Response Trajectories and Clinical Correlates of Residual Albuminuria in Diabetic Kidney Disease During Finerenone Therapy: A Real-World Longitudinal Study.
AU  - Zhang Y
AU  - Zhu Q
AU  - Wang C
AU  - Cai X
AU  - Lin S
AU  - Ding B
AU  - Zhu X
AU  - Lin Y
PY  - 2026
JO  - Diabetes, metabolic syndrome and obesity : targets and therapy
DO  - 10.2147/dmso.s638418
UR  - https://doi.org/10.2147/dmso.s638418
ER  - 

APA

Y, Z., Q, Z., C, W., X, C., S, L., B, D., X, Z., & Y, L. (2026). Twenty-Four-Week UACR Response Trajectories and Clinical Correlates of Residual Albuminuria in Diabetic Kidney Disease During Finerenone Therapy: A Real-World Longitudinal Study.. Diabetes, metabolic syndrome and obesity : targets and therapy. https://doi.org/10.2147/dmso.s638418

Source records